These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

503 related items for PubMed ID: 25755481

  • 21. Novel poly (ADP-ribose) polymerase 1 binding motif in hepatitis B virus core promoter impairs DNA damage repair.
    Ko HL, Ren EC.
    Hepatology; 2011 Oct; 54(4):1190-8. PubMed ID: 21721027
    [Abstract] [Full Text] [Related]

  • 22. D e novo synthesis of hepatitis B virus nucleocapsids is dispensable for the maintenance and transcriptional regulation of cccDNA.
    Tu T, Zehnder B, Qu B, Urban S.
    JHEP Rep; 2021 Feb; 3(1):100195. PubMed ID: 33385130
    [Abstract] [Full Text] [Related]

  • 23. Factors and virological significance of hepatitis B virus pregenomic RNA status after 5 years of antiviral therapy.
    Pan J, Xu J, Luo H, Tan N, Kang Q, Chen H, Cheng R, Han Y, Yang Y, Xu X.
    Int J Infect Dis; 2021 Apr; 105():418-423. PubMed ID: 33676002
    [Abstract] [Full Text] [Related]

  • 24. Dual role of neddylation in transcription of hepatitis B virus RNAs from cccDNA and production of viral surface antigen.
    Qu B, Nebioglu F, Leuthold MM, Ni Y, Mutz P, Beneke J, Erfle H, Vondran FWR, Bartenschlager R, Urban S.
    JHEP Rep; 2022 Oct; 4(10):100551. PubMed ID: 36124123
    [Abstract] [Full Text] [Related]

  • 25. The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitro.
    Salpini R, Surdo M, Cortese MF, Palumbo GA, Carioti L, Cappiello G, Spanò A, Trimoulet P, Fleury H, Vecchiet J, Pasquazzi C, Mirabelli C, Scutari R, Sacco A, Alkhatib M, Missale G, Francioso S, Sarmati L, Andreoni M, Angelico M, Ceccherini-Silberstein F, Levrero M, Perno CF, Belloni L, Svicher V.
    Clin Microbiol Infect; 2019 Jul; 25(7):906.e1-906.e7. PubMed ID: 30472417
    [Abstract] [Full Text] [Related]

  • 26. Serum HBV pregenomic RNA is correlated with Th1/Th2 immunity in treatment-naïve chronic hepatitis B patients.
    Gu Y, Chen L, Lian Y, Gu L, Chen Y, Bi Y, Huang Z, Huang Y, Hu B, Huang Y.
    J Med Virol; 2020 Mar; 92(3):317-328. PubMed ID: 31642539
    [Abstract] [Full Text] [Related]

  • 27. Effect of oxymatrine on the replication cycle of hepatitis B virus in vitro.
    Xu WS, Zhao KK, Miao XH, Ni W, Cai X, Zhang RQ, Wang JX.
    World J Gastroenterol; 2010 Apr 28; 16(16):2028-37. PubMed ID: 20419842
    [Abstract] [Full Text] [Related]

  • 28. Targeted long-read sequencing reveals clonally expanded HBV-associated chromosomal translocations in patients with chronic hepatitis B.
    van Buuren N, Ramirez R, Soulette C, Suri V, Han D, May L, Turner S, Parvangada PC, Martin R, Chan HLY, Marcellin P, Buti M, Bui N, Bhardwaj N, Gaggar A, Li L, Mo H, Feierbach B.
    JHEP Rep; 2022 Apr 28; 4(4):100449. PubMed ID: 35295767
    [Abstract] [Full Text] [Related]

  • 29. Serum HBV DNA plus RNA shows superiority in reflecting the activity of intrahepatic cccDNA in treatment-naïve HBV-infected individuals.
    Huang H, Wang J, Li W, Chen R, Chen X, Zhang F, Xu D, Lu F.
    J Clin Virol; 2018 Apr 28; 99-100():71-78. PubMed ID: 29353073
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Asymmetric Modification of Hepatitis B Virus (HBV) Genomes by an Endogenous Cytidine Deaminase inside HBV Cores Informs a Model of Reverse Transcription.
    Nair S, Zlotnick A.
    J Virol; 2018 May 15; 92(10):. PubMed ID: 29491156
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. IL28B is associated with outcomes of chronic HBV infection.
    Shi X, Chi X, Pan Y, Gao Y, Li W, Yang C, Zhong J, Xu D, Zhang M, Minuk G, Jiang J, Niu J.
    Yonsei Med J; 2015 May 15; 56(3):625-33. PubMed ID: 25837166
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Interaction of hepatitis B virus X protein with PARP1 results in inhibition of DNA repair in hepatocellular carcinoma.
    Na TY, Ka NL, Rhee H, Kyeong D, Kim MH, Seong JK, Park YN, Lee MO.
    Oncogene; 2016 Oct 13; 35(41):5435-5445. PubMed ID: 27041572
    [Abstract] [Full Text] [Related]

  • 38. Reduced ADP-ribosylation by PARP1 natural polymorphism V762A and by PARP1 inhibitors enhance Hepatitis B virus replication.
    Ko HL, Ng HJ, Goh EH, Ren EC.
    J Viral Hepat; 2013 Sep 13; 20(9):658-65. PubMed ID: 23910651
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Kinetics of DNA damage repair response accompanying initial hepadnavirus-host genomic integration in woodchuck hepatitis virus infection of hepatocyte.
    Chauhan R, Michalak TI.
    Cancer Genet; 2020 Jun 13; 244():1-10. PubMed ID: 32062411
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.